المرضى الدوليونالأخباراتصل بنا
مستشفيات جامعةحاجت تبه
موعد
AR
  1. Home
  2. الأطباء
  3. أ.د. Umut Kalyoncu
أ.د. Umut Kalyoncu

أ.د.

Umut Kalyoncu

Rheumatology · مستشفى البالغين

احجز موعدًا

This page is not yet available in العربية. The Turkish version is shown below.

Publications

Source: Hacettepe University academic database (AVESİS) · All publications (339) ↗

Articles 270

  1. Efficacy and safety of leflunomide with tumor necrosis factor inhibitors in psoriatic arthritis: a retrospective analysisÇAKIR İ. Y., BİLGİN E., FIRLATAN YAZGAN B., EKİCİ M., Bayram G. S. K., ÜNALDI E., et al.Clinical Rheumatology, cilt.45, sa.9, ss.5553-5562, 2026 (SCI-Expanded, Scopus)
  2. GRAPPA 2025 Annual Meeting Report: Session on Geographic Variations in Psoriatic Arthritis/Psoriasis Care and Resource LimitationsMa E. J., Boit R., Leung Y. Y., Singla S., Fernández-Ávila D., KALYONCU U., et al.The Journal of rheumatology, cilt.53, ss.41-43, 2026 (SCI-Expanded, Scopus)
  3. Global epidemiology of psoriatic arthritisKALYONCU U., AYAN G.Best Practice and Research: Clinical Rheumatology, cilt.40, sa.3, 2026 (SCI-Expanded, Scopus)
  4. Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS StudyTorgutalp M., Almodovar R., Azevedo V. F., Baraliakos X., Bosch F. V. d., Braun J., et al.Annals of the Rheumatic Diseases, cilt.85, sa.6, ss.1092-1109, 2026 (SCI-Expanded, Scopus)
  5. Baseline body mass index and early functional recovery after first recorded advanced therapy in rheumatoid arthritis: a real-world cohort studyTatar O. D., KILIÇ L., KALYONCU U., ERTENLİ A. İ.Rheumatology International, cilt.46, sa.6, 2026 (SCI-Expanded, Scopus)
  6. Structural changes of pelvic/hip entheses and their evolution over time in psoriatic arthritis patients starting bDMARDsAYAN G., SADIÇ A., Kılıç L., Kalyoncu U.Acta Medica, cilt.57, sa.1, ss.17-24, 2026 (TRDizin)
  7. Clinical significance of non-infectious procalcitonin elevation in Still’s disease: a predictor of macrophage activation syndromeBektas E., ULUDOĞAN B. C., Firlatan Yazgan B., Kilinc O. C., Acar B., Kizilkaya O., et al.Rheumatology, cilt.65, sa.2, 2026 (SCI-Expanded, Scopus)
  8. Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registryAta E. B., KILIÇ L., Fırlatan Yazgan B., Kart Bayram S. G., Ekici M., Ünaldı E., et al.Clinical Rheumatology, cilt.45, sa.2, ss.781-789, 2026 (SCI-Expanded, Scopus)
  9. Turkish adaptation and psychometric testing of the Perceived Workplace Support Scale in people with inflammatory arthritisBUMİN G., GÜNDOĞMUŞ E., Tennant A., KARAHAN S., KALYONCU U., Prior Y.Rheumatology Advances in Practice, cilt.10, sa.3, 2026 (ESCI, Scopus)
  10. EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritisMarzo-Ortega H., Harrison S. R., Fragoulis G. E., Michelena X., Macía-Villa C., Aydin S. Z., et al.Annals of the Rheumatic Diseases, cilt.85, sa.1, ss.61-74, 2026 (SCI-Expanded, Scopus)
  11. Relapse in adult idiopathic inflammatory myopathies: clinical predictors and the potential role of anti-NXP2 in a single-center retrospective cohort studyEKİCİ M., İçli İ. Y., YARDIMCI G. K., ÖZSOY Z., ÜNALDI E., Fırlatan B., et al.Clinical Rheumatology, 2026 (SCI-Expanded, Scopus)
  12. Cross-cultural adaptation and psychometric testing of the Turkish Version of the Workplace Activity Limitations Scale (WALS) in people with inflammatory arthritisBUMİN G., GÜNDOĞMUŞ E., Tennant A., KARAHAN S., KALYONCU U., Prior Y.Rheumatology Advances in Practice, cilt.10, sa.1, 2026 (ESCI, Scopus)
  13. Exaggerated axial osteoproliferation in patients with spondyloarthritis accompanying chronic kidney diseaseUzun G. S., APAYDIN ROLLAS A. E., HABERAL G., YETER H. H., AYAN G., ERDEM Y., et al.Clinical Rheumatology, 2026 (SCI-Expanded, Scopus)
  14. Translation, validity and reliability of the Turkish Chronic Illness Job Strain Scale (CIJSS) in people with inflammatory arthritisBUMİN G., GÜNDOĞMUŞ E., Tennant A., KARAHAN S., KALYONCU U., Prior Y.Rheumatology Advances in Practice, cilt.10, sa.1, 2026 (ESCI, Scopus)
  15. Validity and reliability of the Turkish version of "The Occupational Circumstances Assessment Interview and Rating Scale" in rheumatic diseasesAKYÜREK G., BUMİN G., Onal G., Unal B., GÖKMEN D., ERDEN A., et al.BRITISH JOURNAL OF OCCUPATIONAL THERAPY, cilt.88, ss.344-351, 2025 (SCI-Expanded, SSCI, Scopus)
  16. Serum immunoreactivity to neurofilament-medium shows high sensitivity and specificity in patients with Behçet diseaseAKBABA T. H., DEMİR B. N., Colpak A. I., AKKAYA ULUM Z. Y., Ayan G., ERDENER Ş. E., et al.RMD OPEN, cilt.11, sa.2, 2025 (SCI-Expanded, Scopus)
  17. Real-World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney DiseaseGokten D. B., Tezcan M. E., YAĞIZ B., ERDEN A., KİMYON G., YAŞAR BİLGE N. Ş., et al.INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, cilt.28, sa.5, 2025 (SCI-Expanded, Scopus)
  18. Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP studyLopez-Medina C., Gorlier C., Orbai A., Coates L. C., Kiltz U., Leung Y., et al.RHEUMATOLOGY, cilt.64, ss.3090-3094, 2025 (SCI-Expanded, Scopus)
  19. Association Between Patient Perception of Disease Status and Different Components of the Minimal Disease Activity Criteria in Psoriatic ArthritisYazji S. M., Helliwell P. S., Balanescu A., Dernis E., Kiltz U., KALYONCU U., et al.JOURNAL OF RHEUMATOLOGY, cilt.52, sa.4, ss.362-367, 2025 (SCI-Expanded, Scopus)
  20. Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experienceEdiboglu E. D., KALYONCU U., SOLMAZ D., YAŞAR BİLGE N. Ş., Yilmaz S., Bes C., et al.ARCHIVES OF RHEUMATOLOGY, cilt.40, sa.1, ss.1-14, 2025 (SCI-Expanded, Scopus, TRDizin)
  21. ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritisUzun G. S., SARIKAYA Y., Arslan S., EKİCİ M., ATA E. B., KARCIOĞLU O., et al.CLINICAL RHEUMATOLOGY, cilt.44, sa.3, ss.1031-1040, 2025 (SCI-Expanded, Scopus)
  22. Comparison of functionality, mood, and biopsychosocial status in rheumatic patients with and without self-reported bowel problems and the evaluation of BETY's impact on these factors: a retrospective studyKaraca N. B., KAHRAMAN A., BURAN S., Tufekci O., KUMBAROĞLU F. B., Bulut Z. I., et al.CURRENT MEDICAL RESEARCH AND OPINION, cilt.41, ss.691-697, 2025 (SCI-Expanded, Scopus)
  23. Hip involvement and its impact on treatment decision in patients with axial spondyloarthritis; treasure experienceEdiboglu E. D., KALYONCU U., PEHLİVAN Y., AKAR S.JOINT BONE SPINE, cilt.91, sa.6, 2024 (SCI-Expanded, Scopus)
  24. Factors Associated with the Development of Anti-drug Antibodies to TNFi and the Consequences for Axial Spondyloarthritis: A Two-year Follow-up StudyEdiboglu E. D., Cinar M., KOZACI L. D., SOLMAZ D., Sargin G., KARADAĞ Ö., et al.EUROPEAN JOURNAL OF RHEUMATOLOGY, cilt.11, sa.3, ss.364-370, 2024 (ESCI, TRDizin)
  25. Liver fibrosis in inflammatory arthritis patients treated with methotrexate and hydroxychloroquine: A FIB-4 index analysisUzun G. S., Bulat B., AYAN G., KILIÇ L., KALYONCU U.INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, cilt.27, sa.10, 2024 (SCI-Expanded, Scopus)
  26. Nationwide study on the prevalence of rheumatoid factor and anticitrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosisSATIŞ H., ERDEN A., BİLGİN E., AYAN G., ARMAĞAN B., TECER D., et al.Turkish Journal of Medical Sciences, cilt.54, sa.5, ss.949-955, 2024 (SCI-Expanded, Scopus, TRDizin)
  27. Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registrySARIYILDIZ E., ÜNALDI E., KILIÇ L., KARADAĞ Ö., KALYONCU U., ERTENLİ A. İ., et al.Acta Medica, cilt.55, sa.3, ss.214-221, 2024 (TRDizin)
  28. Predicting Disease Flares in Axial Spondyloarthritis Using Machine Learning in the METEOR-SpA RegistryBenavent D., Fanjul V., Bergstra S. A., van Gaalen F., Dougados M., KALYONCU U., et al.ARTHRITIS & RHEUMATOLOGY, ss.1134-1136, 2024 (SCI-Expanded, Scopus)
  29. PsAID12 Thresholds Defining Disease Impact Severity in Psoriatic Arthritis Developed in an Observational Setting Showed Higher Sensitivity but Lower Specificity Than Those Developed in a Randomized Controlled Trial SettingLopez Medina C., Orbai A., Lubrano E., Coates L., Kiltz U., Leung Y. Y., et al.ARTHRITIS & RHEUMATOLOGY, ss.4697-4699, 2024 (SCI-Expanded, Scopus)
  30. Characteristics of Patients with Psoriatic Arthritis Presenting with Axial Involvement: Results of a Prospective International Multicenter Study (AXIS)Torgutalp M., Azevedo V., Baraliakos X., Van den Bosch F., Braun J., Cauli A., et al.ARTHRITIS & RHEUMATOLOGY, ss.4700-4703, 2024 (SCI-Expanded, Scopus)
  31. Unmet needs in psoriatic arthritis, a narrative reviewLopez-Medina C., KALYONCU U., Gossec L.ARCHIVES OF RHEUMATOLOGY, cilt.39, sa.2, ss.159-171, 2024 (SCI-Expanded, Scopus, TRDizin)
  32. Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era-results from a nationwide studySari A., Satis H., AYAN G., KÜÇÜKŞAHİN O., KALYONCU U., Fidanci A. A., et al.CLINICAL RHEUMATOLOGY, cilt.43, sa.6, ss.1919-1925, 2024 (SCI-Expanded, Scopus)
  33. Apical fibrobullous lung disease in spondyloarthritis patients with biologic DMARDs indicationÖZSOY Z., AYAN G., DURHAN G., KALYONCU U.Rheumatology (United Kingdom), cilt.63, sa.4, ss.1147-1152, 2024 (SCI-Expanded, Scopus)
  34. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: Real life experience from the TReasure RegistryKARADAĞ Ö., Farisogullari B., YAĞIZ B., Erden A., Ademoglu Z., Kimyon G., et al.Clinical and Experimental Rheumatology, cilt.42, sa.1, ss.130-137, 2024 (SCI-Expanded, Scopus)
  35. Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality ratesSandal Uzun G., Taghiyeva A., Çakır İ. Y., Moral K., YARDIMCI G. K., Bölek E. Ç., et al.International Journal of Rheumatic Diseases, cilt.27, sa.1, 2024 (SCI-Expanded, Scopus)
  36. The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up studyYAĞIZ B., Lermi N., COŞKUN B. N., DALKILIÇ H. E., KİRAZ S., Erden A., et al.Rheumatology (United Kingdom), cilt.62, sa.12, ss.3962-3967, 2023 (SCI-Expanded, Scopus)
  37. Costovertebral and costotransverse joint involvement in spondyloarthritisATA E. B., DURHAN G., BİLGİN E., ARIYÜREK O. M., KALYONCU U.International Journal of Rheumatic Diseases, cilt.26, sa.11, ss.2141-2150, 2023 (SCI-Expanded, Scopus)
  38. The Frequency and Importance of Subchondral Radius Cysts in Rheumatoid Arthritis Patients Under B/tsDMARDsKALYONCU U., AYAN G.ARTHRITIS & RHEUMATOLOGY, ss.3731-3734, 2023 (SCI-Expanded, Scopus)
  39. Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Phenotypes Using Unsupervised Hierarchical Clustering Analysis: Results from a Large Collaborative International StudyJuge P., Granger B., El Houari L., McDermott G., Doyle T. J., Kelly C., et al.ARTHRITIS & RHEUMATOLOGY, ss.1551-1554, 2023 (SCI-Expanded, Scopus)
  40. Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional studyLeung Y. Y., Eder L., Orbai A., Coates L. C., de Wit M., Smolen J. S., et al.RMD open, cilt.9, sa.3, 2023 (SCI-Expanded, Scopus)
  41. Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure databaseErsözlü E. D., EKİCİ M., COŞKUN B. N., Badak S. Ö., BİLGİN E., KALYONCU U., et al.Archives of Rheumatology, cilt.38, sa.3, ss.347-357, 2023 (SCI-Expanded, Scopus, TRDizin)
  42. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO RegistryDuran E., Ozturk Z. O., BİLGİN E., BÜYÜKAŞIK Y., DİZDAR Ö., Yardimci G. K., et al.Rheumatology and Therapy, cilt.10, sa.4, ss.969-981, 2023 (SCI-Expanded, Scopus)
  43. Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countriesSousa M., Lubrano E., Smolen J. S., Gorlier C., de Wit M., Coates L. C., et al.Joint Bone Spine, cilt.90, sa.3, 2023 (SCI-Expanded, Scopus)
  44. Comparison of lupus nephritis and non-lupus nephritides in patients with systemic lupus erythematosusDURAN E., BİLGİN E., KALYONCU U., ERTENLİ A. İ., YILDIRIM T., ARICI M., et al.Ulusal Romatoloji Dergisi, cilt.15, sa.1, ss.18-24, 2023 (Scopus, TRDizin)
  45. Acute stroke in familial Mediterranean fever: An analysis of 23 new cases and systematic review of the literatureTOPÇUOĞLU M. A., AYVACIOĞLU ÇAĞAN C., ARSAVA E. M., Acar-Ozen P., KALYONCU U., GÖÇMEN R., et al.International Journal of Rheumatic Diseases, cilt.26, sa.4, ss.657-666, 2023 (SCI-Expanded, Scopus)
  46. Clinical and laboratory factors associated with bamboo spine in patients with axial spondyloarthritis: are there clues for bamboo spine?Atagündüz P., KİRAZ S., Akar S., KÜÇÜKŞAHİN O., Erden A., Aksoy A., et al.Clinical and Experimental Rheumatology, cilt.41, sa.3, ss.620-627, 2023 (SCI-Expanded, Scopus)
  47. The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel diseaseKESKİN O., Farisogullari B., YARDIMCI G. K., GÜRBÜZ B., Kole M., PARLAK E., et al.Frontiers in Medicine, cilt.10, 2023 (SCI-Expanded, Scopus)
  48. Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)Erden A., AYAN G., KILIÇ L., Solmaz D., Bakirci S., Kimyon G., et al.Clinical Rheumatology, cilt.42, sa.2, ss.385-390, 2023 (SCI-Expanded, Scopus)
  49. New Onset Isolated Granulomatous Dacryoadenitis During Etanercept TherapyÖZKAN ARAT Y., BEZCİ AYGÜN F., ÖZOĞUL E., KALYONCU U.OCULAR IMMUNOLOGY AND INFLAMMATION, cilt.31, sa.8, ss.1727-1729, 2023 (SCI-Expanded, Scopus)
  50. Craniocervical junction involvement in inflammatory arthritis: a single-center radiologic studyYALÇINKAYA F., PARLAK SAĞOL Ş., Azizova A., BİLGİN E., Karli Oğuz K., KALYONCU U.Turkish Journal of Medical Sciences, cilt.53, sa.6, ss.1713-1721, 2023 (SCI-Expanded, Scopus, TRDizin)
  51. Derivation and validation of adult Still Activity Score (SAS)KALYONCU U., KAŞİFOĞLU T., Omma A., Bes C., Cinar M., EMMUNGİL H., et al.Joint Bone Spine, cilt.90, sa.1, 2023 (SCI-Expanded, Scopus)
  52. Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritisArmagan B., KILIÇ L., Farisogullari B., YARDIMCI G. K., Bilgin E., BÖLEK E. Ç., et al.RHEUMATOLOGY INTERNATIONAL, cilt.43, sa.1, ss.147-156, 2023 (SCI-Expanded, Scopus)
  53. The impact of antiphospholipid antibodies in Takayasu arteritisFirat Şentürk E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KALYONCU U., et al.Turkish Journal of Medical Sciences, cilt.53, sa.1, ss.199-205, 2023 (SCI-Expanded, Scopus, TRDizin)
  54. Adaptation and psychometric testing of the Turkish evaluation of daily activity questionnaire in people with rheumatoid arthritisBUMİN G., Hammond A., Akarsu R., Prior Y., Kaplan B., Temizkan F., et al.Disability and Rehabilitation, 2023 (SCI-Expanded, SSCI, Scopus)
  55. The reliability, validity, and responsiveness of Cognitive Exercise Therapy Approach: Biopsychosocial Questionnaire for patients with psoriatic arthritisBulut S., KARAKAYA KARABULUT J., Oksuz S., KALYONCU U., ÜNAL E.RHEUMATOLOGY INTERNATIONAL, cilt.42, sa.11, ss.1973-1981, 2022 (SCI-Expanded, Scopus)
  56. Effectiveness and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life dataKALYONCU U., BİLGİN E., Erden A., Satış H., TUFAN A., Tekgöz E., et al.Clinical and Experimental Rheumatology, cilt.40, sa.11, ss.2071-2077, 2022 (SCI-Expanded, Scopus)
  57. Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?Ilgen U., KARADAĞ Ö., Emmungil H., KÜÇÜKŞAHİN O., KOCA S. S., Erden A., et al.RHEUMATOLOGY INTERNATIONAL, cilt.42, sa.10, ss.1797-1806, 2022 (SCI-Expanded, Scopus)
  58. Recurrent Aphthous Stomatitis and Related Factors in Turkish Adult Population: A Striking Outcome of Cappadocia Chronic Diseases Epidemiological StudyÇALIK BAŞARAN N., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., ERDEN A., KILIÇ L., et al.Cumhuriyet Tıp Dergisi (ELEKTRONİK), cilt.44, sa.3, ss.233-238, 2022 (Hakemli Dergi)
  59. Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational studyDİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., Inanc N., KOCA S. S., et al.RHEUMATOLOGY ADVANCES IN PRACTICE, cilt.6, sa.3, 2022 (ESCI, Scopus)
  60. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experienceSARIYILDIZ E., YILDIRIM T., Taghiyeva A., Bilgin E., ARICI M., Saglam E. A., et al.LUPUS, cilt.31, ss.1147-1156, 2022 (SCI-Expanded, Scopus)

All 270 on AVESİS →

Conference papers 69

  1. S07. Investigation of the Relationship Between the Disease Diagnoses According to the Hand Involvement Expressed by Individuals Diagnosed with Rheumatism and the Relationship Between Functionality, Anxiety-Depression, and Biopsychosocial Characteristics of IndividualsTüfekçi O., Barlak A., KARACA N. B., BURAN S., EKİCİ M., KALYONCU U., et al.9th National 1st International Rheumatological Rehabilitation Congress, İzmir, Türkiye, 7 - 09 Ekim 2024, (Özet Bildiri)
  2. Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life ResultsFARİSOĞULLARI B., YARDIMCI G. K., SARI A., ARMAĞAN B., BİLGİN E., BÖLEK E. Ç., et al.2019 ACR/ARP Annual Meeting, 8 - 13 Kasım 2019, (Özet Bildiri)
  3. Psöriatik artrit hastalar›nda 5 yıllık anti-TNF alfa kullanımı sonrasında subklinik aterosklerozun değişimiERDEN A., CANPOLAT U., UYAROĞLU O. A., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.233-234, (Özet Bildiri)
  4. UVEITIS RELATED FACTORS IN PATIENTS WITH SPONDYLOARTHRITISBilge N. S. Y., KAŞİFOĞLU T., KİRAZ S., ERTENLİ A. İ., Kucuksahin O., Dalkilic E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.491, (Özet Bildiri)
  5. GO-BEYOND: A REAL-WORLD PERSISTENCE STUDY WITH GOLIMUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND RHEUMATOID ARTHRITIS IN TURKEYAKAR S., KALYONCU U., Dalkili E., EMMUNGİL H.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.2159-2160, (Özet Bildiri)
  6. COMPARISON OF SURVIVAL RATES AMONG SUBGROUPS OF PATIENTS EVALUATED FOR FEVER OF UNKNOWN ORIGINBİLGİN E., ARMAĞAN B., SARI A., BÖLEK E. Ç., Farisogullari B., YARDIMCI G. K., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.573, (Özet Bildiri)
  7. ENTEROPATHIC ARTHRITIS PATIENTS UNDER BDMARD TREATMENTS HAD FREQUENTLY RADIOGRAPHIC SACROILIITIS: HUR-BIO REAL LIFE RESULTSYARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.478, (Özet Bildiri)
  8. PREVALENCE, UNDERLYING FACTORS AND DAMAGE ASSOCIATED WITH CHRONIC PERSISTENT INFLAMMATION IN PATIENTS WITH FMFBABAOĞLU H., ARMAĞAN B., Bodakci E., KAŞİFOĞLU T., Satis H., Atas N., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.571-572, (Özet Bildiri)
  9. FOOT PRESSURE DISTRIBUTION AND FUNCTIONAL LEVELS: ANKYLOSING SPONDYLITIS VS CONTROLSSari N., GÜNEY DENİZ H., Kalyoncu U., Baltaci G., Sari N. B.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1461, (Özet Bildiri)
  10. CLINICAL FEATURES OF ANEURYSMAL BEHCET DISEASEARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1182, (Özet Bildiri)
  11. PULMONARY FUNCTIONS AND RESPIRATORY MUSCLE PERFORMANCE CORRELATE WITH NIGHT PAIN IN PATIENTS WITH ANKYLOSING SPONDYLITIS COMPARED TO CONTROLSTaskin B., VARDAR YAĞLI N., Kalyoncu U., Baltaci G.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1461, (Özet Bildiri)
  12. SMOKING MAY BE RELATED TO SACROILIITIS IN ENTEROPATHIC ARTHRITIS PATIENTS: TREASURE REAL-LIFE PRELIMINARY DATAKucuksahin O., ERDEN A., Ilgen U., KİRAZ S., ERTENLİ A. İ., Bilge N. S. Y., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1824-1825, (Özet Bildiri)
  13. DERIVATION AND VALIDATION OF A NEW STILL ACTIVITY SCORE (SAS)KALYONCU U., KAŞİFOĞLU T., Omma A., BES C., Cinar M., EMMUNGİL H., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.159-160, (Özet Bildiri)
  14. APPLICATION OF AUTO-INFLAMMATORY DISEASE DAMAGE INDEX (ADDI) TO PATIENTS WITH FMF AND RELATED FACTORS WITH DAMAGEBABAOĞLU H., ARMAĞAN B., Bodakci E., KAŞİFOĞLU T., Satis H., Atas N., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1005, (Özet Bildiri)
  15. ANEURYSM IN BEHCET'S DISEASE: MANAGEMENT, PROGNOSIS AND MORTALITYARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.422, (Özet Bildiri)
  16. CEREBROVASCULAR EVENT CAN BE THE PRESENTING FEATURE OF TAKAYASU ARTERITIS: RESULTS OF A PROSPECTIVE VASCULITIS CENTERSARI A., BÖLEK E. Ç., KILIÇ L., ARSAVA E. M., TOPÇUOĞLU M. A., KALYONCU U., et al.19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
  17. VALIDATION OF THE GIANT CELL ARTERITIS CLASSIFICATION CRITERIA IN TURKISH PATIENTSARMAĞAN B., YILDIRIM A., Onur M., Yardimci G., KILIÇ L., KALYONCU U., et al.19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
  18. Anevrizması olan Behçet hastalar›n tedavisi, prognozu ve mortalitesiArmagan B., Bolek E. C., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., BİLGİN E., et al.XIX. Ulusal Romatoloji Kongresi2, Türkiye, 26 - 30 Ekim 2018, (Özet Bildiri)
  19. ANTİ-TNF TEDAVİSİ ALMASI KARARLAŞTIRILMIŞ ANKİLOZAN SPONDİLİTLİ BİREYLERDE EŞ ZAMANLI BAŞLANAN BİLİŞSEL EGZERSİZ TERAPİ YAKLAŞIMI’xxNINHASTALARIN BİYOPSİKOSOSYAL DURUMLARI ÜZERİNE ETKİSİKARACA N. B., OFLAZ F. B., ÖZÇADIRCI A., ARIN G., KALYONCU U., ÜNAL E., et al.19. Ulusal Romatoloji Kongresi, Türkiye, 26 - 30 Eylül 2018, (Özet Bildiri)
  20. Arteriyel anevrizması olan Behçet hastalarnın klinik özellikleriArmagan B., Bolek E. C., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., BİLGİN E., et al.XIX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.68-69, (Özet Bildiri)
  21. Frequency of pulmonary hypertension in Behçet’s diseaseARMAĞAN B., Oksul M., ŞENER Y. Z., SARI A., ERDEN A., YARDIMCI G. K., et al.EULAR Annual European Congress of Rheumatology, 13 Haziran - 16 Ağustos 2018, cilt.77, (Özet Bildiri)
  22. What Does Evidence Based Medicine Tell Us on Treatments of Different Psoriatic Arthritis Subtypes? A Systematic Literature Review on Randomized Controlled TrialsUreyen S., Ivory C., KALYONCU U., Karsh J., Aydin S.73rd Annual Meeting of The Canadian-Rheumatology-Association (CRA), Vancouver, Kanada, 21 - 24 Şubat 2018, cilt.45, ss.1000, (Özet Bildiri)
  23. Sistemik Lupus Eritematozus Hastalarında Serebral Mikrohemoraji PaternleriBULUT E. G., OMAY B., ARDALI S., SARI A., KALYONCU U., AKDOĞAN A., et al.Türk Nöroradyoloji Derneği 27. yıl yıllık toplantısı, İstanbul, Türkiye, 16 - 18 Şubat 2018, (Özet Bildiri)
  24. ANTİ-TNF TEDAVİSİ ALMASI KARARLAŞTIRILMIŞ ANKİLOZAN SPONDİLİTLİ BİREYLERİN YAŞAM KALİTELERİ İLE FONKSİYONELLİKLERİ ARASINDAKİ İLİŞKİNİN İNCELENMESİKARACA N. B., ARIN G., OFLAZ F. B., KALYONCU U., GÖKSÜLÜK D., ÜNAL E.3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, (Özet Bildiri)
  25. ANKİLOZAN SPONDİLİT HASTALARINDA HASTALIK AKTİVİTESİ VE FONKSİYONELLİK ARASINDAKİ İLİŞKİNİN İNCELENMESİARIN G., TÜRKMEN N. B., OFLAZ F. B., SARI A., ARMAĞAN B., KALYONCU U., et al.3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, ss.22, (Özet Bildiri)
  26. ANTİ-TNF TEDAVİSİ ALMASI KARARLAŞTIRILMIŞ ANKİLOZAN SPONDİLİTLİ BİREYLERİN BİLİŞSEL FONKSİYONLARI İLE DEPRESYON VE ANKSİYETELERİ ARASINDAKİ İLİŞKİNİN İNCELENMESİTÜRKMEN N. B., ARIN G., OFLAZ F. B., GÖKSÜLÜK D., KALYONCU U., ÜNAL E.3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, (Özet Bildiri)
  27. Enthesitis in the Axial Skeleton An Overview of MRI findings in Patients with SpondyloarthritisERGEN F. B., AYDINGÖZ Ü., KALYONCU U.RSNA 2017, 26 Kasım - 01 Aralık 2017, (Özet Bildiri)
  28. Dermatoloji uzmani ve uzmanlik ogrencilerinin psoriazisli hastalarda romatolojik sorgulama yapma aliskanligina iliskin anket calismasıDOĞAN GÜNAYDIN S., KALYONCU U., ATAKAN Z. N.23. lütfü tat simpozyumu, Türkiye, 22 - 26 Kasım 2017, (Özet Bildiri)
  29. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis Hur-BIO Real Life ExperiencesUYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
  30. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?ERDEN A., BATU E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., FIRAT E., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
  31. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial SpondyloarthritisSARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
  32. Sjögren Sendromu’nun Kas Güçsüzlüğü ile Prezantasyonu: Renal Tubuler Asidoz Tip 1BÖLEK E. Ç., ERDEN A., KOÇ H., KARADAĞ Ö., KALYONCU U., KİRAZ S., et al.19.Ulusal İç Hastalıkları Kongresi, Türkiye, 11 - 15 Ekim 2017, (Tam Metin Bildiri)
  33. A Section of Rare Diseases in Hacettepe Adult Clinics in Rheumatology: Deficiency of Adenosine Deaminase 2 (DADA2)BÖLEK E. Ç., ERDEN A., ÖZEN S., KARADAĞ Ö., KALYONCU U., BATU E. D., et al.5th Rare Diseases Summer School, 7 - 09 Haziran 2017, (Tam Metin Bildiri)
  34. Psoriasis Symptom Inventory (PSI) as a Patient-Reported Outcome in Mild Psoriasis: Real-life Data from a Large Psoriatic Arthritis RegistryAydin S., Ureyen S., KALYONCU U.72nd Annual Meeting of the Canadian-Rheumatology-Association (CRA), Ottawa, Kanada, 8 - 11 Şubat 2017, cilt.44, ss.922, (Özet Bildiri)
  35. Syndesmophytes in Axial Psoriatic Arthritis-Where Should We Start Screening?Aydin S., Ureyen S., KALYONCU U.72nd Annual Meeting of the Canadian-Rheumatology-Association (CRA), Ottawa, Kanada, 8 - 11 Şubat 2017, cilt.44, ss.921-922, (Özet Bildiri)
  36. The Significance of Syndesmophytes in Psoriatic Arthritis and Risk FactorsAydin S., Ureyen S., KALYONCU U.72nd Annual Meeting of the Canadian-Rheumatology-Association (CRA), Ottawa, Kanada, 8 - 11 Şubat 2017, cilt.44, ss.922, (Özet Bildiri)
  37. . IGG4-RELATED DISEASE IN EASTERN MEDITERRANEAN: CLINICAL FEATURES AND OUTCOMES OF A LARGE COHORTKARADAĞ Ö., ERDEN A., AYHAN E. A., BÖLEK E. Ç., ARMAĞAN B., KILIÇ L., et al.EULAR 2017, 6 - 10 Haziran 2017, cilt.76, ss.720, (Özet Bildiri)
  38. PRESENTATION OF A NEW SCALE ASSESSING THE BIOPSYCHOSOCIAL ASPECTS OF HEALING PROPERTIES IN RHEUMATIC PATIENTSÜNAL E., KISACIK P., Arin G., KARABULUT E., GÖKSÜLÜK D., Yagli N. V., et al.Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1531, (Özet Bildiri)
  39. STROKE IN FAMILIAL MEDITERRANEAN FEVERTOPÇUOĞLU M. A., ARSAVA E. M., KALYONCU U., GÖÇMEN R., KARLI OĞUZ H. K., TUNCER M. A.3rd European Stroke Organisation Conference, 22 - 24 Mayıs 2017, (Özet Bildiri)
  40. Stroke in Familial Mediterraean Fever.TOPÇUOĞLU M. A., ARSAVA E. M., KALYONCU U., GÖÇMEN R., KARLI OĞUZ H. K., TUNCER M. A.European Stroke Organization Congress, 16 - 18 Mayıs 2017, (Özet Bildiri)
  41. Comorbidity and Surgery History of Rheumatoid Arthritis Patients Who Receiving Biological AgentARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.MIRCIM 2017 TIHUD-TIP JOINT MEETING, Krakow, Polonya, 11 - 14 Mayıs 2017, (Özet Bildiri)
  42. SCALP NECROSIS IN NEUROFIBROMATOSIS TYPE-1 VASCULOPATHY: A DIAGNOSTIC DILEMMAGuven D., SARI A., ARMAĞAN B., KİRAZ S., KILIÇ L., KARADAĞ Ö., et al.18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.101-102, (Özet Bildiri)
  43. EVALUATION OF ASSSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES OR LUPUS ANTICOAGULANT POSITIVITY AND SEVERITY OF VASCULAR INVOLVEMENT IN TAKAYASU ARTERITIS PATIENTSFIRAT E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KALYONCU U., et al.18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.48, (Özet Bildiri)
  44. SUCCESSFUL TREATMENT OF AORTOENTERIC FISTULA A PATIENT WITH BEHCET DISEASE INTERFERON ALFA2A AND SURGERYARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KALYONCU U., KARADAĞ Ö.18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri)
  45. AGREEMENT OF PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OF DISEASE ACTIVITY IN ADULT ONSET STILL'S DISEASEKALYONCU U., Kasifoglu T., Kisacik B., Oksuz M. F., Omma A., Bes C., et al.Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.404, (Özet Bildiri)
  46. Comorbidities in patients with Familial Mediterranean FeverB Balci P., ARICI Z. S., Avcı E., BATU E. D., Arslanoğlu E., Burak Ç., et al.8th International congressof familial mediterranean fever and systemic autoinflammatory diseases, 30 Eylül - 03 Ekim 2015
  47. Adrenal insufficiency due to antiphospholipid syndrome in a patient with MTHFR C677T mutationŞENER Y. Z., ÖZIŞIK L., ERDEN A., DURUSU TANRIÖVER M., KALYONCU U., BAYRAKTAR M.14th European Congress of Internal Medicine, 13 - 17 Ekim 2015, ss.328-329
  48. The time course of pseudo-conduction blocks in a patient with vasculitic neuropathyBekircan-Kurt C. E., KALYONCU U., ERDEM-OZDAMAR S., TEMUÇİN Ç. M.Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)
  49. Amyloidosis and Its Related Factors In Patients With Familial Mediterranean Fever: A Nationwide Multicenter Study.KAŞİFOĞLU T., Yasar S., Sari I., Solmaz D., Senel S., Emmungil H., et al.77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)
  50. AB0430 WHAT IS THE ROLE OF AMBULATORY BLOOD PRESSURE MONITORING IN SLEER E., AKDOĞAN A., KILIÇ L., CANPOLAT U., KAYA E. B., KARADAĞ Ö., et al.European League Against Rheumatism (EULAR) Congress, 12-15 June, 2013; Madrid-Spain., 12 - 15 Haziran 2013
  51. AB0589 SUBCLINICAL ATHEROSCLEROSIS FOUND BOTH IN PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITISAPRAŞ BİLGEN Ş. Ş., KALYONCU U., KILIÇ L., KARADAĞ Ö., CANPOLAT U., AYTEMİR K., et al.European League Against Rheumatism (EULAR) Congress, 12-15 June, 2013; Madrid-Spain., 12 - 15 Haziran 2013
  52. Patient-Perceived Impact of Psoriatic Arthritis Is Due to Pain and Fatigue, but Also to Psychological Aspects - the Psa Impact of Disease StudyGossec L., de Wit M., Balanescu A., Balint P. V., Bekes G., Braun J., et al.75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)
  53. THE RATE AND CAUSES OF SWITCHING AMONG THE RHEUMATIC PATIENTS UNDER BIOLOGIC THERAPY: FINDINGS FROM TURKISH RHEUMATOLOGY DATABASE-ROMADIGITALKaradag O., Yilmaz S., Kisacik B., KALYONCU U., Tezcan E., YILMAZ S., et al.Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)
  54. Ascariasis Mimicking An Acute Abdomen at The Patient With Familial Mediterranean FeverERBİL B., KARACA M. A., ÖZÜÇELİK D. N., Abdulhayoğlu E., Şimşek A., Kalyoncu U., et al.1st Eurasian Congress on Emergency Medicine, 5 - 09 Kasım 2008, ss.175
  55. Longitudinal ultrasonographic assessment of achilles enthesitis in patients with Ankylosing S ondylitis following anti-TNF therapyAydin S. Z., Karadag O., Filippucci E., Atagunduz P., AKDOĞAN A., KALYONCU U., et al.72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Kostarika, 24 - 29 Ekim 2008, cilt.58, (Özet Bildiri)
  56. Ankylosing spondylitis has a more severe disease course when coexist with Familial Mediterranean Fever.Calguneri M., Kalyoncu U., Akdogan A., Karadag O., Maras Y., Kisacik B., et al.70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54, ss.4050-4051, (Özet Bildiri)
  57. Anti TNF treatment may induce EBV reactivation in RA patients A clue for increased risk of lymphomaTOKGÖZOĞLU S. L., ERTENLİ A. İ., KALYONCU U., ALP A., KARADAĞ Ö., ERMAN M., et al.Annual European Congress of Rheumatology (EULAR 2006), 21 - 24 Haziran 2006, (Tam Metin Bildiri)
  58. Novel cardiovascular risk factors and cardiac event predictors in systemic lupus erythematosusKaradag O., Calguneri M., Yavuz B., Akdogan A., Atalar E., Kalyoncu U., et al.Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237, (Özet Bildiri)
  59. Impaired endothelium-dependent flow-mediated dilatation in Behcet's disease does not correlate with disease activityAkdogan A., Sahiner L., Kalyoncu U., Yavuz B., Calguneri M., Aytemir K., et al.Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.263, (Özet Bildiri)
  60. Does chest expansion ability influence flexibility and functional status in unspeedy movements in patients with ankylosing spondylitis? - A pilot studyYakut E., Vardar N., Kiraz S., Akdooan A., Kalyoncu U., Calguneri M., et al.Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.604, (Özet Bildiri)

All 69 on AVESİS →

اتصل بنا

Department
Rheumatology, مستشفى البالغين

آخر تحديث: